HYGIENE A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS A61P3/00Drugs for disorders of the metabolism AHUMAN NECESSITIES A61MEDICAL OR VETERINARY SCIENCE
Structurally its a pentapeptide Aib-His-D-2Nal-D-Phe-Lys-NH and those non-standard residues at positions 1 and 3 (alpha-aminoisobutyric acid and D-beta-naphthylalanine) turn out to be doing most of the pharmacological work
The difference is that oral tirzepatide dosing targets appetite and metabolism directly, making results consistent
GLP-1 High-Conviction Addition: Long ESTA US Keeping you abreast of the situation with our GLP-1 basket, I already teased this new addition in the chat: We are adding Long ESTA as a GLP-1 secondary beneficiary at a 7.5% weight, considering my expectation that breast augmentation surgeries will see a surge in volume off the back of higher than modeled weight loss and the effects weight loss has on extra skin / breast size
Studies show that stopping the medication can sometimes, but not always, cause a persons weight to creep back up, along with blood pressure, blood sugar and cholesterol levels
This setup helps prevent product degradation because you only dissolve what you need for immediate testing
